8Renner S,Krumpelmann S,Bruchelt G,et al.Effect of amifostine on neuroblastoma during high dose chemotherapy:in vivo and in vitro investigations.Anticancer Res,2000,20(6B):4531-4538.
9Viniou N,Terpos E,Galanopoulos A,et al.Treatment of anemia in low-risk myelodysplastic syndromes with amifostine.In vitro testing of response.Ann Hematol,2002,81(4):182-186.
10Ribizzi I,Darnowsk JW,Goulette FA,et al.Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line.Leuk Res,2000,24(6):519-524.
2[2]Mohr P,Makki A,Breibbart E,et al.Combined treatment of stage IV melanoma patients with amifostine and fotemustine-a pilot study[J].Melanoma Res ,1998,8(2):166～169.
3[3]Alberts DS,Bleyeer WA.Future development of amifostine in cancer treatment [J].Semin Oncol,1996,23:90～99.
4[4]Schuchter LM,Glicd J.The current status of WR-2721(amifostine):a chemotherapy and radiation therapy protector[J].Biol Ther Cancer,1993,3:1.
5[5]Van der vijgh WJ,Peters GJ.Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine:preclinical aspects[J].Semin Oncol 1994,2115(suppl 111):2～7.
6[6]Aviles A,Diaz-Jaqueo JC,Talavera A.Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma[J].Eur J Cancer,1997,33(8):1323～1325.
7[1]Hospers CAP, Eisanhauer EA , Vries de EGE, et al. The sulfhydryl containing compounds WR-2721 and glutathione as radio and chemoprotective agents: a review, indications for use and prospects [J]. Br J Cancer, 1999,80(5-6) :629-638.
8[2]Hensley ML, Schuchter LM, Lindley C, et al. American Society of Clinical Oncology: clinical practice guidelines for the use of chemotherapy and radiotherapy protectants [J]. J Clin Oncol,1999,171(10):3333-3353.
9[3]Capizzi RL. The preclinical basis for broad-spectrum selective cytoprotection of normal tissue from cytotoxic therapies by amifostine [J]. Semin Oncol, 1999,26 ( 2 Suppl 7 ):3-21.
10[4]Sviles A, Diza Maqueo JC, Talavera A, et al. Protective of amifostine on hematopoiesi in lymphoma with high risk prognosis [J].Eur J Cancer, 1997,33(8): 1323-1325.
7TCHANQUE-FOSSUO C N, DONNEYS A, DESHPANDE S S, et al. Amifostine remediates the degenerative effects of radiation on the mineralization capacity of the routine mandible [J]. Plast Reeonstr Surg, 2012,129(4) : 646e-655e.
8OZDEMIR C S, BURGAZLI K M, BEKEN-OZDEMIR E, et al. The effect of Amifostine (Ethyol) on intestinal anastomosis in rats with radiation enteritis[J]. Eur Rev Med Pharmacol Sci, 2013,17(10) =1351-1359.
9YAVUZ A A, AYDIN F, YAVUZ M N, et al. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic can- cer[J]. Int J Radiat Oncol Biol Phys, 2001,51(4) :974-981.
10PHAN T P, CRANE C H, JANJAN N A, et al. WR-2721 re- duces intestinal toxicity from concurrent gemcitabinc and radi- ation treatment[J], lnt J Pancreatol, 2001,29(1) : 19-23.
